T Cells in Tumors and Blood Predict Outcome in Follicular Lymphoma Treated with Rituximab

T cells influence outcome in follicular lymphoma, but their contributions seem to be modified by therapy. Their impact in patients receiving rituximab without chemotherapy is unknown. Using flow cytometry, we evaluated the T cells in tumors and/or blood in a total of 250 follicular lymphoma patients...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical cancer research 2011-06, Vol.17 (12), p.4136-4144
Hauptverfasser:	WAHLIN, Björn Engelbrekt, SUNDSTRÖM, Christer, DE NULLY BROWN, Peter, LEHTINEN, Tuula, MAISENHÖLDER, Martin, TIERENS, Anne M, SANDER, Birgitta, CHRISTENSSON, Birger, KIMBY, Eva, HOLTE, Harald, HAGBERG, Hans, ERLANSON, Martin, NILSSON-EHLE, Herman, LINDEN, Ola, NORDSTRÖM, Marie, ØSTENSTAD, Bjorn, GEISLER, Christian H
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antibodies, Monoclonal, Murine-Derived - therapeutic use Antineoplastic agents Antineoplastic Agents - therapeutic use Biological and medical sciences Cancer and Oncology Cancer och onkologi Clinical Medicine Hematologic and hematopoietic diseases Humans Interferon-alpha - therapeutic use Kirurgi Klinisk medicin Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphocyte Subsets - metabolism Lymphoma, Follicular - diagnosis Lymphoma, Follicular - drug therapy Lymphoma, Follicular - metabolism Male Medical and Health Sciences Medical sciences MEDICIN Medicin och hälsovetenskap MEDICINE Middle Aged Oncology Onkologi Pathology Patologi Pharmacology. Drug treatments Prognosis Rituximab Surgery Survival Analysis T-Lymphocytes - metabolism Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!